[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Hepatitis B Human Immunoglobulin Market - Global Outlook and Forecast 2021-2027

April 2021 | 107 pages | ID: H381A2E1B5B7EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Hepatitis B Human Immunoglobulin in global, including the following market information:

Global Hepatitis B Human Immunoglobulin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Hepatitis B Human Immunoglobulin Market Sales, 2016-2021, 2022-2027, (Litre)

Global top five Hepatitis B Human Immunoglobulin companies in 2020 (%)

The global Hepatitis B Human Immunoglobulin market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hepatitis B Human Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hepatitis B Human Immunoglobulin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, By Type, 2020 (%)
  • 100IU
  • 200IU
  • 400IU
Global Hepatitis B Human Immunoglobulin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, By Application, 2020 (%)
  • Measles Prevention
  • Prevention of Hepatitis B Virus Infection
  • Hepatitis A Virus Infection
  • Other
Global Hepatitis B Human Immunoglobulin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (Litre)

Global Hepatitis B Human Immunoglobulin Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hepatitis B Human Immunoglobulin revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Hepatitis B Human Immunoglobulin revenues share in global market, 2020 (%)

Key companies Hepatitis B Human Immunoglobulin sales in global market, 2016-2021 (Estimated), (Litre)

Key companies Hepatitis B Human Immunoglobulin sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Biotest
  • ADMA Biologics
  • Sanquin Blood
  • Bio Products Laboratory
  • Baxter
  • CSL
  • Bayer
  • Grifols
  • Octapharma
  • Hualan Biological
  • China Biologic
  • Tiantan Biologic
  • Shuanglin Bio-pharmacy
  • Sichuan Yuanda Shuyang
  • Shanghai Institute of Biological
  • Hualan
  • Shanghai RAAS Blood Products
  • China Grand Enterprises
  • Nanyue Biopharmaceutical
  • Boya Biopharmaceutical Group
  • Tonglu Biopharmaceutical
  • Shandong Taibang Biopharmaceutical
  • Guangdong Shuanglin Biopharmaceutical
  • Chengdu Rongsheng Pharmaceutical
  • Shenzhen Weiguang Biopharmaceutical
  • Green Cross (China) Biological Products
  • Sinopharm
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hepatitis B Human Immunoglobulin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hepatitis B Human Immunoglobulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HEPATITIS B HUMAN IMMUNOGLOBULIN OVERALL MARKET SIZE

2.1 Global Hepatitis B Human Immunoglobulin Market Size: 2021 VS 2027
2.2 Global Hepatitis B Human Immunoglobulin Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Hepatitis B Human Immunoglobulin Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Hepatitis B Human Immunoglobulin Players in Global Market
3.2 Top Global Hepatitis B Human Immunoglobulin Companies Ranked by Revenue
3.3 Global Hepatitis B Human Immunoglobulin Revenue by Companies
3.4 Global Hepatitis B Human Immunoglobulin Sales by Companies
3.5 Global Hepatitis B Human Immunoglobulin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Hepatitis B Human Immunoglobulin Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Hepatitis B Human Immunoglobulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Players in Global Market
  3.8.1 List of Global Tier 1 Hepatitis B Human Immunoglobulin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Hepatitis B Human Immunoglobulin Market Size Markets, 2021 & 2027
  4.1.2 100IU
  4.1.3 200IU
  4.1.4 400IU
4.2 By Type - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
  4.2.1 By Type - Global Hepatitis B Human Immunoglobulin Revenue, 2016-2021
  4.2.2 By Type - Global Hepatitis B Human Immunoglobulin Revenue, 2022-2027
  4.2.3 By Type - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
4.3 By Type - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
  4.3.1 By Type - Global Hepatitis B Human Immunoglobulin Sales, 2016-2021
  4.3.2 By Type - Global Hepatitis B Human Immunoglobulin Sales, 2022-2027
  4.3.3 By Type - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
4.4 By Type - Global Hepatitis B Human Immunoglobulin Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hepatitis B Human Immunoglobulin Market Size, 2021 & 2027
  5.1.2 Measles Prevention
  5.1.3 Prevention of Hepatitis B Virus Infection
  5.1.4 Hepatitis A Virus Infection
  5.1.5 Other
5.2 By Application - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
  5.2.1 By Application - Global Hepatitis B Human Immunoglobulin Revenue, 2016-2021
  5.2.2 By Application - Global Hepatitis B Human Immunoglobulin Revenue, 2022-2027
  5.2.3 By Application - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
5.3 By Application - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
  5.3.1 By Application - Global Hepatitis B Human Immunoglobulin Sales, 2016-2021
  5.3.2 By Application - Global Hepatitis B Human Immunoglobulin Sales, 2022-2027
  5.3.3 By Application - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
5.4 By Application - Global Hepatitis B Human Immunoglobulin Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Hepatitis B Human Immunoglobulin Market Size, 2021 & 2027
6.2 By Region - Global Hepatitis B Human Immunoglobulin Revenue & Forecasts
  6.2.1 By Region - Global Hepatitis B Human Immunoglobulin Revenue, 2016-2021
  6.2.2 By Region - Global Hepatitis B Human Immunoglobulin Revenue, 2022-2027
  6.2.3 By Region - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
6.3 By Region - Global Hepatitis B Human Immunoglobulin Sales & Forecasts
  6.3.1 By Region - Global Hepatitis B Human Immunoglobulin Sales, 2016-2021
  6.3.2 By Region - Global Hepatitis B Human Immunoglobulin Sales, 2022-2027
  6.3.3 By Region - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Hepatitis B Human Immunoglobulin Revenue, 2016-2027
  6.4.2 By Country - North America Hepatitis B Human Immunoglobulin Sales, 2016-2027
  6.4.3 US Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.4.4 Canada Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.4.5 Mexico Hepatitis B Human Immunoglobulin Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Hepatitis B Human Immunoglobulin Revenue, 2016-2027
  6.5.2 By Country - Europe Hepatitis B Human Immunoglobulin Sales, 2016-2027
  6.5.3 Germany Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.4 France Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.5 U.K. Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.6 Italy Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.7 Russia Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.8 Nordic Countries Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.5.9 Benelux Hepatitis B Human Immunoglobulin Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Hepatitis B Human Immunoglobulin Revenue, 2016-2027
  6.6.2 By Region - Asia Hepatitis B Human Immunoglobulin Sales, 2016-2027
  6.6.3 China Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.6.4 Japan Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.6.5 South Korea Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.6.6 Southeast Asia Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.6.7 India Hepatitis B Human Immunoglobulin Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Hepatitis B Human Immunoglobulin Revenue, 2016-2027
  6.7.2 By Country - South America Hepatitis B Human Immunoglobulin Sales, 2016-2027
  6.7.3 Brazil Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.7.4 Argentina Hepatitis B Human Immunoglobulin Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, 2016-2027
  6.8.3 Turkey Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.8.4 Israel Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.8.5 Saudi Arabia Hepatitis B Human Immunoglobulin Market Size, 2016-2027
  6.8.6 UAE Hepatitis B Human Immunoglobulin Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Biotest
  7.1.1 Biotest Corporate Summary
  7.1.2 Biotest Business Overview
  7.1.3 Biotest Hepatitis B Human Immunoglobulin Major Product Offerings
  7.1.4 Biotest Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.1.5 Biotest Key News
7.2 ADMA Biologics
  7.2.1 ADMA Biologics Corporate Summary
  7.2.2 ADMA Biologics Business Overview
  7.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Major Product Offerings
  7.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.2.5 ADMA Biologics Key News
7.3 Sanquin Blood
  7.3.1 Sanquin Blood Corporate Summary
  7.3.2 Sanquin Blood Business Overview
  7.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Major Product Offerings
  7.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.3.5 Sanquin Blood Key News
7.4 Bio Products Laboratory
  7.4.1 Bio Products Laboratory Corporate Summary
  7.4.2 Bio Products Laboratory Business Overview
  7.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Major Product Offerings
  7.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.4.5 Bio Products Laboratory Key News
7.5 Baxter
  7.5.1 Baxter Corporate Summary
  7.5.2 Baxter Business Overview
  7.5.3 Baxter Hepatitis B Human Immunoglobulin Major Product Offerings
  7.5.4 Baxter Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.5.5 Baxter Key News
7.6 CSL
  7.6.1 CSL Corporate Summary
  7.6.2 CSL Business Overview
  7.6.3 CSL Hepatitis B Human Immunoglobulin Major Product Offerings
  7.6.4 CSL Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.6.5 CSL Key News
7.7 Bayer
  7.7.1 Bayer Corporate Summary
  7.7.2 Bayer Business Overview
  7.7.3 Bayer Hepatitis B Human Immunoglobulin Major Product Offerings
  7.4.4 Bayer Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.7.5 Bayer Key News
7.8 Grifols
  7.8.1 Grifols Corporate Summary
  7.8.2 Grifols Business Overview
  7.8.3 Grifols Hepatitis B Human Immunoglobulin Major Product Offerings
  7.8.4 Grifols Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.8.5 Grifols Key News
7.9 Octapharma
  7.9.1 Octapharma Corporate Summary
  7.9.2 Octapharma Business Overview
  7.9.3 Octapharma Hepatitis B Human Immunoglobulin Major Product Offerings
  7.9.4 Octapharma Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.9.5 Octapharma Key News
7.10 Hualan Biological
  7.10.1 Hualan Biological Corporate Summary
  7.10.2 Hualan Biological Business Overview
  7.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Major Product Offerings
  7.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.10.5 Hualan Biological Key News
7.11 China Biologic
  7.11.1 China Biologic Corporate Summary
  7.11.2 China Biologic Hepatitis B Human Immunoglobulin Business Overview
  7.11.3 China Biologic Hepatitis B Human Immunoglobulin Major Product Offerings
  7.11.4 China Biologic Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.11.5 China Biologic Key News
7.12 Tiantan Biologic
  7.12.1 Tiantan Biologic Corporate Summary
  7.12.2 Tiantan Biologic Hepatitis B Human Immunoglobulin Business Overview
  7.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Major Product Offerings
  7.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.12.5 Tiantan Biologic Key News
7.13 Shuanglin Bio-pharmacy
  7.13.1 Shuanglin Bio-pharmacy Corporate Summary
  7.13.2 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Business Overview
  7.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Major Product Offerings
  7.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.13.5 Shuanglin Bio-pharmacy Key News
7.14 Sichuan Yuanda Shuyang
  7.14.1 Sichuan Yuanda Shuyang Corporate Summary
  7.14.2 Sichuan Yuanda Shuyang Business Overview
  7.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Major Product Offerings
  7.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.14.5 Sichuan Yuanda Shuyang Key News
7.15 Shanghai Institute of Biological
  7.15.1 Shanghai Institute of Biological Corporate Summary
  7.15.2 Shanghai Institute of Biological Business Overview
  7.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Major Product Offerings
  7.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.15.5 Shanghai Institute of Biological Key News
7.16 Hualan
  7.16.1 Hualan Corporate Summary
  7.16.2 Hualan Business Overview
  7.16.3 Hualan Hepatitis B Human Immunoglobulin Major Product Offerings
  7.16.4 Hualan Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.16.5 Hualan Key News
7.17 Shanghai RAAS Blood Products
  7.17.1 Shanghai RAAS Blood Products Corporate Summary
  7.17.2 Shanghai RAAS Blood Products Business Overview
  7.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Major Product Offerings
  7.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.17.5 Shanghai RAAS Blood Products Key News
7.18 China Grand Enterprises
  7.18.1 China Grand Enterprises Corporate Summary
  7.18.2 China Grand Enterprises Business Overview
  7.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Major Product Offerings
  7.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.18.5 China Grand Enterprises Key News
7.19 Nanyue Biopharmaceutical
  7.19.1 Nanyue Biopharmaceutical Corporate Summary
  7.19.2 Nanyue Biopharmaceutical Business Overview
  7.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.19.5 Nanyue Biopharmaceutical Key News
7.20 Boya Biopharmaceutical Group
  7.20.1 Boya Biopharmaceutical Group Corporate Summary
  7.20.2 Boya Biopharmaceutical Group Business Overview
  7.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Major Product Offerings
  7.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.20.5 Boya Biopharmaceutical Group Key News
7.21 Tonglu Biopharmaceutical
  7.21.1 Tonglu Biopharmaceutical Corporate Summary
  7.21.2 Tonglu Biopharmaceutical Business Overview
  7.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.21.5 Tonglu Biopharmaceutical Key News
7.22 Shandong Taibang Biopharmaceutical
  7.22.1 Shandong Taibang Biopharmaceutical Corporate Summary
  7.22.2 Shandong Taibang Biopharmaceutical Business Overview
  7.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.22.5 Shandong Taibang Biopharmaceutical Key News
7.23 Guangdong Shuanglin Biopharmaceutical
  7.23.1 Guangdong Shuanglin Biopharmaceutical Corporate Summary
  7.23.2 Guangdong Shuanglin Biopharmaceutical Business Overview
  7.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.23.5 Guangdong Shuanglin Biopharmaceutical Key News
7.24 Chengdu Rongsheng Pharmaceutical
  7.24.1 Chengdu Rongsheng Pharmaceutical Corporate Summary
  7.24.2 Chengdu Rongsheng Pharmaceutical Business Overview
  7.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.24.5 Chengdu Rongsheng Pharmaceutical Key News
7.25 Shenzhen Weiguang Biopharmaceutical
  7.25.1 Shenzhen Weiguang Biopharmaceutical Corporate Summary
  7.25.2 Shenzhen Weiguang Biopharmaceutical Business Overview
  7.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Major Product Offerings
  7.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.25.5 Shenzhen Weiguang Biopharmaceutical Key News
7.26 Green Cross (China) Biological Products
  7.26.1 Green Cross (China) Biological Products Corporate Summary
  7.26.2 Green Cross (China) Biological Products Business Overview
  7.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Major Product Offerings
  7.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.26.5 Green Cross (China) Biological Products Key News
7.27 Sinopharm
  7.27.1 Sinopharm Corporate Summary
  7.27.2 Sinopharm Business Overview
  7.27.3 Sinopharm Hepatitis B Human Immunoglobulin Major Product Offerings
  7.27.4 Sinopharm Hepatitis B Human Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.27.5 Sinopharm Key News

8 GLOBAL HEPATITIS B HUMAN IMMUNOGLOBULIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Hepatitis B Human Immunoglobulin Production Capacity, 2016-2027
8.2 Hepatitis B Human Immunoglobulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Hepatitis B Human Immunoglobulin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 HEPATITIS B HUMAN IMMUNOGLOBULIN SUPPLY CHAIN ANALYSIS

10.1 Hepatitis B Human Immunoglobulin Industry Value Chain
10.2 Hepatitis B Human Immunoglobulin Upstream Market
10.3 Hepatitis B Human Immunoglobulin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Hepatitis B Human Immunoglobulin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Hepatitis B Human Immunoglobulin in Global Market
Table 2. Top Hepatitis B Human Immunoglobulin Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Hepatitis B Human Immunoglobulin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Hepatitis B Human Immunoglobulin Revenue Share by Companies, 2016-2021
Table 5. Global Hepatitis B Human Immunoglobulin Sales by Companies, (Litre), 2016-2021
Table 6. Global Hepatitis B Human Immunoglobulin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Hepatitis B Human Immunoglobulin Price (2016-2021) & (US$/ML)
Table 8. Global Manufacturers Hepatitis B Human Immunoglobulin Product Type
Table 9. List of Global Tier 1 Hepatitis B Human Immunoglobulin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hepatitis B Human Immunoglobulin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2016-2021
Table 15. By Type - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2022-2027
Table 16. By Application – Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2016-2021
Table 20. By Application - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2022-2027
Table 21. By Region – Global Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Hepatitis B Human Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2016-2021
Table 25. By Region - Global Hepatitis B Human Immunoglobulin Sales (Litre), 2022-2027
Table 26. By Country - North America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Hepatitis B Human Immunoglobulin Sales, (Litre), 2016-2021
Table 29. By Country - North America Hepatitis B Human Immunoglobulin Sales, (Litre), 2022-2027
Table 30. By Country - Europe Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Hepatitis B Human Immunoglobulin Sales, (Litre), 2016-2021
Table 33. By Country - Europe Hepatitis B Human Immunoglobulin Sales, (Litre), 2022-2027
Table 34. By Region - Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Hepatitis B Human Immunoglobulin Sales, (Litre), 2016-2021
Table 37. By Region - Asia Hepatitis B Human Immunoglobulin Sales, (Litre), 2022-2027
Table 38. By Country - South America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Hepatitis B Human Immunoglobulin Sales, (Litre), 2016-2021
Table 41. By Country - South America Hepatitis B Human Immunoglobulin Sales, (Litre), 2022-2027
Table 42. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, (Litre), 2016-2021
Table 45. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales, (Litre), 2022-2027
Table 46. Biotest Corporate Summary
Table 47. Biotest Hepatitis B Human Immunoglobulin Product Offerings
Table 48. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 49. ADMA Biologics Corporate Summary
Table 50. ADMA Biologics Hepatitis B Human Immunoglobulin Product Offerings
Table 51. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 52. Sanquin Blood Corporate Summary
Table 53. Sanquin Blood Hepatitis B Human Immunoglobulin Product Offerings
Table 54. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 55. Bio Products Laboratory Corporate Summary
Table 56. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product Offerings
Table 57. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 58. Baxter Corporate Summary
Table 59. Baxter Hepatitis B Human Immunoglobulin Product Offerings
Table 60. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 61. CSL Corporate Summary
Table 62. CSL Hepatitis B Human Immunoglobulin Product Offerings
Table 63. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 64. Bayer Corporate Summary
Table 65. Bayer Hepatitis B Human Immunoglobulin Product Offerings
Table 66. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 67. Grifols Corporate Summary
Table 68. Grifols Hepatitis B Human Immunoglobulin Product Offerings
Table 69. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 70. Octapharma Corporate Summary
Table 71. Octapharma Hepatitis B Human Immunoglobulin Product Offerings
Table 72. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 73. Hualan Biological Corporate Summary
Table 74. Hualan Biological Hepatitis B Human Immunoglobulin Product Offerings
Table 75. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 76. China Biologic Corporate Summary
Table 77. China Biologic Hepatitis B Human Immunoglobulin Product Offerings
Table 78. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 79. Tiantan Biologic Corporate Summary
Table 80. Tiantan Biologic Hepatitis B Human Immunoglobulin Product Offerings
Table 81. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 82. Shuanglin Bio-pharmacy Corporate Summary
Table 83. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product Offerings
Table 84. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 85. Sichuan Yuanda Shuyang Corporate Summary
Table 86. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product Offerings
Table 87. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 88. Shanghai Institute of Biological Corporate Summary
Table 89. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product Offerings
Table 90. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 91. Hualan Corporate Summary
Table 92. Hualan Hepatitis B Human Immunoglobulin Product Offerings
Table 93. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 94. Shanghai RAAS Blood Products Corporate Summary
Table 95. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product Offerings
Table 96. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 97. China Grand Enterprises Corporate Summary
Table 98. China Grand Enterprises Hepatitis B Human Immunoglobulin Product Offerings
Table 99. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 100. Nanyue Biopharmaceutical Corporate Summary
Table 101. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 102. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 103. Boya Biopharmaceutical Group Corporate Summary
Table 104. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product Offerings
Table 105. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 106. Tonglu Biopharmaceutical Corporate Summary
Table 107. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 108. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 109. Shandong Taibang Biopharmaceutical Corporate Summary
Table 110. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 111. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 112. Guangdong Shuanglin Biopharmaceutical Corporate Summary
Table 113. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 114. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 115. Chengdu Rongsheng Pharmaceutical Corporate Summary
Table 116. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 117. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 118. Shenzhen Weiguang Biopharmaceutical Corporate Summary
Table 119. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product Offerings
Table 120. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 121. Green Cross (China) Biological Products Corporate Summary
Table 122. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product Offerings
Table 123. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 124. Sinopharm Corporate Summary
Table 125. Sinopharm Hepatitis B Human Immunoglobulin Product Offerings
Table 126. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Revenue (US$, Mn) and Average Price (US$/ML) (2016-2021)
Table 127. Hepatitis B Human Immunoglobulin Production Capacity (Litre) of Key Manufacturers in Global Market, 2019-2021 (Litre)
Table 128. Global Hepatitis B Human Immunoglobulin Capacity Market Share of Key Manufacturers, 2019-2021
Table 129. Global Hepatitis B Human Immunoglobulin Production by Region, 2016-2021 (Litre)
Table 130. Global Hepatitis B Human Immunoglobulin Production by Region, 2022-2027 (Litre)
Table 131. Hepatitis B Human Immunoglobulin Market Opportunities & Trends in Global Market
Table 132. Hepatitis B Human Immunoglobulin Market Drivers in Global Market
Table 133. Hepatitis B Human Immunoglobulin Market Restraints in Global Market
Table 134. Hepatitis B Human Immunoglobulin Raw Materials
Table 135. Hepatitis B Human Immunoglobulin Raw Materials Suppliers in Global Market
Table 136. Typical Hepatitis B Human Immunoglobulin Downstream
Table 137. Hepatitis B Human Immunoglobulin Downstream Clients in Global Market
Table 138. Hepatitis B Human Immunoglobulin Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Hepatitis B Human Immunoglobulin Segment by Type
Figure 2. Hepatitis B Human Immunoglobulin Segment by Application
Figure 3. Global Hepatitis B Human Immunoglobulin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Hepatitis B Human Immunoglobulin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Hepatitis B Human Immunoglobulin Revenue, 2016-2027 (US$, Mn)
Figure 7. Hepatitis B Human Immunoglobulin Sales in Global Market: 2016-2027 (Litre)
Figure 8. The Top 3 and 5 Players Market Share by Hepatitis B Human Immunoglobulin Revenue in 2020
Figure 9. By Type - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 10. By Type - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 11. By Type - Global Hepatitis B Human Immunoglobulin Price (US$/ML), 2016-2027
Figure 12. By Application - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 13. By Application - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 14. By Application - Global Hepatitis B Human Immunoglobulin Price (US$/ML), 2016-2027
Figure 15. By Region - Global Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 16. By Region - Global Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 17. By Country - North America Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 18. By Country - North America Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 19. US Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 24. Germany Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 25. France Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 33. China Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 37. India Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 39. By Country - South America Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 40. Brazil Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share, 2016-2027
Figure 44. Turkey Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Hepatitis B Human Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 48. Global Hepatitis B Human Immunoglobulin Production Capacity (Litre), 2016-2027
Figure 49. The Percentage of Production Hepatitis B Human Immunoglobulin by Region, 2020 VS 2027
Figure 50. Hepatitis B Human Immunoglobulin Industry Value Chain
Figure 51. Marketing Channels


More Publications